Jackson SR - Search Results

1

Targeting CD8+ T-cell tolerance for cancer immunotherapy.

Jackson SR, Yuan J, Teague RM. Jackson SR, et al. Immunotherapy. 2014;6(7):833-52. doi: 10.2217/imt.14.51. Immunotherapy. 2014. PMID: 25290416 Free PMC article. Review.

2

Durable adoptive immunotherapy for leukemia produced by manipulation of multiple regulatory pathways of CD8+ T-cell tolerance.

Berrien-Elliott MM, Jackson SR, Meyer JM, Rouskey CJ, Nguyen TL, Yagita H, Greenberg PD, DiPaolo RJ, Teague RM. Berrien-Elliott MM, et al. Among authors: jackson sr. Cancer Res. 2013 Jan 15;73(2):605-16. doi: 10.1158/0008-5472.CAN-12-2179. Epub 2012 Nov 27. Cancer Res. 2013. PMID: 23188506 Free PMC article.

3

CD8+ T cell exhaustion during persistent viral infection is regulated independently of the virus-specific T cell receptor.

Jackson SR, Berrien-Elliott MM, Meyer JM, Wherry EJ, Teague RM. Jackson SR, et al. Immunol Invest. 2013;42(3):204-20. doi: 10.3109/08820139.2012.751397. Epub 2013 Mar 5. Immunol Invest. 2013. PMID: 23461613 Free PMC article.

4

Inflammation programs self-reactive CD8+ T cells to acquire T-box-mediated effector function but does not prevent deletional tolerance.

Jackson SR, Yuan J, Berrien-Elliott MM, Chen CL, Meyer JM, Donlin MJ, Teague RM. Jackson SR, et al. J Leukoc Biol. 2014 Sep;96(3):397-410. doi: 10.1189/jlb.1A0913-500RR. Epub 2014 May 13. J Leukoc Biol. 2014. PMID: 24823810 Free PMC article.

5

Neuropilin-1 expression is induced on tolerant self-reactive CD8+ T cells but is dispensable for the tolerant phenotype.

Jackson SR, Berrien-Elliott M, Yuan J, Hsueh EC, Teague RM. Jackson SR, et al. PLoS One. 2014 Oct 24;9(10):e110707. doi: 10.1371/journal.pone.0110707. eCollection 2014. PLoS One. 2014. PMID: 25343644 Free PMC article.

6

Checkpoint blockade immunotherapy relies on T-bet but not Eomes to induce effector function in tumor-infiltrating CD8+ T cells.

Berrien-Elliott MM, Yuan J, Swier LE, Jackson SR, Chen CL, Donlin MJ, Teague RM. Berrien-Elliott MM, et al. Among authors: jackson sr. Cancer Immunol Res. 2015 Feb;3(2):116-24. doi: 10.1158/2326-6066.CIR-14-0159. Epub 2014 Dec 16. Cancer Immunol Res. 2015. PMID: 25516478 Free PMC article.

7

Advocacy for victims of violent crime.

Jackson S, Edwards-Wills P. Jackson S, et al. Disch Plann Update. 1994 Mar-Apr;14(2):19-23. Disch Plann Update. 1994. PMID: 10137703 No abstract available.

8

A review of sample collection and analytical methods for detecting per- and polyfluoroalkyl substances in indoor and outdoor air.

Wallace MAG, Smeltz MG, Mattila JM, Liberatore HK, Jackson SR, Shields EP, Xhani X, Li EY, Johansson JH. Wallace MAG, et al. Among authors: jackson sr. Chemosphere. 2024 Jun;358:142129. doi: 10.1016/j.chemosphere.2024.142129. Epub 2024 Apr 26. Chemosphere. 2024. PMID: 38679180 Free article. Review.

9

eHealth literacy in prostate cancer: A systematic review.

Jackson SR, Yu P, Armany D, Occhipinti S, Chambers S, Leslie S, Patel MI. Jackson SR, et al. Patient Educ Couns. 2024 Jun;123:108193. doi: 10.1016/j.pec.2024.108193. Epub 2024 Feb 7. Patient Educ Couns. 2024. PMID: 38354430 Free article. Review.

10

A promoterless AAV6.2FF-based lung gene editing platform for the correction of surfactant protein B deficiency.

Thomas SP, Domm JM, van Vloten JP, Xu L, Vadivel A, Yates JGE, Pei Y, Ingrao J, van Lieshout LP, Jackson SR, Minott JA, Achuthan A, Mehrani Y, McAusland TM, Zhang W, Karimi K, Vaughan AE, de Jong J, Kang MH, Thebaud B, Wootton SK. Thomas SP, et al. Among authors: jackson sr. Mol Ther. 2023 Dec 6;31(12):3457-3477. doi: 10.1016/j.ymthe.2023.10.002. Epub 2023 Oct 7. Mol Ther. 2023. PMID: 37805711 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

254 results

Search Page